Chemours Co. Files 8-K on Listing Rule Compliance

Ticker: CC · Form: 8-K · Filed: 2024-03-19T00:00:00.000Z

Sentiment: neutral

Topics: listing-rule, compliance, financials

TL;DR

Chemours 8-K: Potential listing rule issues, filing financials.

AI Summary

On March 18, 2024, The Chemours Company filed an 8-K report to address a notice of delisting or failure to satisfy a continued listing rule. The company is also filing financial statements and exhibits as part of this report. The filing pertains to the company's status as of March 18, 2024.

Why It Matters

This filing indicates potential issues with Chemours' continued listing on an exchange, which could impact investor confidence and stock liquidity.

Risk Assessment

Risk Level: medium — Filings related to listing rules can signal underlying financial or operational difficulties that may affect the company's stock.

Key Numbers

Key Players & Entities

FAQ

What specific listing rule is Chemours failing to satisfy?

The filing does not specify the exact listing rule that Chemours may be failing to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.

What is the date of the earliest event reported in this 8-K?

The date of the earliest event reported is March 18, 2024.

What is the company's principal executive office address?

The company's principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.

What is the company's state of incorporation?

The Chemours Company is incorporated in Delaware.

What other items are being filed as part of this 8-K?

In addition to the notice of delisting, the company is filing 'Financial Statements and Exhibits'.

From the Filing

0001193125-24-070332.txt : 20240319 0001193125-24-070332.hdr.sgml : 20240319 20240318183253 ACCESSION NUMBER: 0001193125-24-070332 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240318 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24760513 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 d809954d8k.htm 8-K 8-K Chemours Co false 0001627223 0001627223 2024-03-18 2024-03-18     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 18, 2024 Date of Report (Date of earliest Event Reported)       The Chemours Company (Exact Name of Registrant as Specified in Its Charter)       Delaware   001-36794   46-4845564 (State or Other Jurisdiction Of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) 1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices) (302) 773-1000 (Registrant’s Telephone Number, Including Area Code) Not Applicable (Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On March 18, 2024, the New York Stock Exchange (the “NYSE”) notified The Chemours Company (the “Company”) that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”). In accordance with the NYSE Listed Company Manual, the Company has contacted the NYSE to discuss the status

View on Read The Filing